“Bis-phossy jaws” – High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

Medicine, Oral Pathology, Oral Surgery +12

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias, Efstathios Kastritis, Christina Bamia et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Medicine, Oncology, Bone Metabolism +9

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian et al. · Cancer · 2004 · 716 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia

Tony Mavrokokki, Andrew Cheng, Alastair N. Goss · Journal of Oral and Maxillofacial Surgery · 2007 · 647 citations

Medicine, Maxillofacial Surgery, Bone Metabolism +6

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

Ashraf Badros, Dianna Weikel, Andrew Salama et al. · Journal of Clinical Oncology · 2006 · 596 citations

Dentistry, Oral Pathology, Oral Radiology +12